Analysis: Pandemic fatigue makes the case for
Some nations are already looking to a fourth vaccine dose to help contend with
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
Some nations are already looking to a fourth vaccine dose to help contend with
Uber Technologies Inc (UBER.N) will let employees work half their hours from wherever they
Here's what you need to know about the coronavirus right now.
Here's what you need to know about the coronavirus right now.
U.S. regulators on Monday approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to
AstraZeneca (AZN.L) will move finance chief Marc Dunoyer to head newly acquired rare diseases
Britain's competition regulator is reviewing AstraZeneca's (AZN.L) $39 billion buyout of U.S.-based Alexion (ALXN.O)